Odyssey Therapeutics, Inc. ODTX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with autoimmune and inflammatory diseases. The company advances a pipeline of small molecule and protein therapeutics that target upstream signaling nodes in the innate immune system to preve…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees100
TickerODTX
Statistics
Market Cap$869.9M
Revenue (TTM)$3.2M
Net Income—
Net Margin—
EPS—
P/E—
P/S275.10
P/B—
EV/EBITDA-4.68
ROE-85.5%
Dividend Yield—
Price$18.44
Data: Twelve Data · Revenue = mcap / P/S